Azenta, Inc. (AZTA) M&A Call March 10, 2026 10:00 AM EDT
Company Participants
Yvonne Perron – Vice President of Financial Planning & Analysis and Investor Relations
John P. Marotta – President, CEO & Director
Lawrence Lin – Executive VP & CFO
Conference Call Participants
David Saxon – Needham & Company, LLC, Research Division
Paul Knight – KeyBanc Capital Markets Inc., Research Division
Steven Etoch – Stephens Inc., Research Division
Brendan Smith – TD Cowen, Research Division
Presentation
Operator
Hello, and welcome. My name is Jenny, and I will be your conference facilitator today for Azenta’s Acquisition of Uk Biocentre Acquisition Call. [Operator Instructions] As a reminder, this conference call is being recorded today, Tuesday, March 10, 2026.
I will now turn the conference call over to Yvonne Perron, Vice President, FP&A and Investor Relations.
Yvonne Perron
Vice President of Financial Planning & Analysis and Investor Relations
Good morning, everyone, and thank you for joining us. As you know, last week, we announced that Azenta entered into a definitive agreement to acquire Uk Biocentre. The press release and a presentation to accompany today’s call are available on the Investor Relations section of our website. Joining me today are John Marotta, President and Chief Executive Officer; and Lawrence Lin, Chief Financial Officer, who will discuss the strategic rationale for the transaction and provide additional details. Before we begin, I will briefly refer you to the safe harbor statements included in the presentation, which outline important information regarding forward-looking statements and the use of non-GAAP financial measures.
With that, I’ll turn the call over to our CEO, John Marotta.
John P. Marotta
President, CEO & Director
Good morning, everyone, and thank you for joining us today. I’ll use the first portion of our time discussing the strategic rationale behind our acquisition of the Uk Biocentre and how this transaction